1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : The HOVON-SAKK-132 trial
(
- Contribution to journal › Article
- 2015
-
Mark
Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.
(
- Contribution to journal › Article
- 2011
-
Mark
Identification of the Drosophila and Tribolium receptors for the recently discovered insect RYamide neuropeptides
(
- Contribution to journal › Article
- 2009
-
Mark
Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients
(
- Contribution to journal › Article
-
Mark
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods
(
- Contribution to journal › Article
-
Mark
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants
(
- Contribution to journal › Article
- 2007
-
Mark
Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
(
- Contribution to journal › Article
- 2003
-
Mark
Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
(
- Contribution to journal › Article